Hepatitis B treatment sees a hold lifted and Ultomiris gains accelerated approval, signaling progress in pharma.
Read More

Hepatitis B treatment sees a hold lifted and Ultomiris gains accelerated approval, signaling progress in pharma.
Read MoreUK cancer drug approval raises questions for PharmaMar investors about potential actions needed.
Read More